1-5 of 5
Daniela Angelini
Close
Sort by
Journal Articles

Mutational Profile of Leukemic Stem Cells in FLT3 -ITD Mutated AML

Tiziana Ottone, Serena Travaglini, Valentina Alfonso, PhD, Daniela Angelini, PhD, Gisella Guerrera, PhD, Serena Lavorgna, Mariadomenica Divona, Anna Maria Nardozza, Antonio Cristiano, Maria irno Consalvo, PhD, Marco de Bardi, PhD, Benedetta Neri, MD, Francesco Marchesi, Carmelo Gurnari, MD, Giovangiacinto Paterno, Vincenza Martini, MD, Luca Battistini, MD, PhD, Adriano Venditti, Francesco Buccisano, MD, William Arcese, Francesco Lo-Coco, Maria Teresa Voso, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1458.
https://doi.org/10.1182/blood-2019-126040
Published: 2019
Journal Articles

Longitudinal Detection of DNMT3A R882H Transcripts in Patients with Acute Myeloid Leukemia

Tiziana Ottone, PhD, Valentina Alfonso, BS, Licia Iaccarino, BS, Syed Khizer Hasan, PhD, Melissa Mancini, PhD, Mariadomenica Divona, BS, Serena Lavorgna, PhD, Laura Cicconi, Paola Panetta, PhD, Luca Maurillo, MD, PhD, Maria Ilaria Del Principe, Maria irno Consalvo, PhD, Luca Franceschini, MD, PhD, Daniela Angelini, PhD, Luca Battistini, MD, PhD, Gisella Guerrera, PhD, Marco de Bardi, PhD, Emiliano Fabiani, PhD, Giulia Falconi, PhD, William Arcese, MD, Sergio Amadori, MD, Francesco Buccisano, MD, Adriano Venditti, MD, Maria Teresa Voso, MD, Francesco Lo Coco, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3959.
https://doi.org/10.1182/blood.V130.Suppl_1.3959.3959
Published: 2017
Journal Articles

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells

Marta Coscia, Candida Vitale, Silvia Peola, Myriam Foglietta, Micol Rigoni, Valentina Griggio, Barbara Castella, Daniela Angelini, Sabina Chiaretti, Chiara Riganti, Anna Guarini, Daniela Drandi, Marco Ladetto, Amalia Bosia, Robin Foà, Luca Battistini, Mario Boccadoro, Jean-Jacques Fournié, Massimo Massaia
Journal: Blood
Blood (2012) 120 (16): 3271–3279.
https://doi.org/10.1182/blood-2012-03-417519
Published: 2012
Includes: Supplemental data
Journal Articles

The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status

Marta Coscia, MD, PhD, Candida Vitale, MD, Silvia Peola, PhD, Chiara Riganti, MD, Daniela Angelini, PhD, Myriam Foglietta, MD, Francesca Pantaleoni, PhD, Giorgia Matta, MD, Sabina Chiaretti, MD, Anna Guarini, PhD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Luca Battistini, MD, Robin Foà, MD, Mario Boccadoro, MD, Jean-Jacques Fournié, PhD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 3602.
https://doi.org/10.1182/blood.V116.21.3602.3602
Published: 2010
Journal Articles

Phenotypic and Functional Features of Vγ9/Vδ2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells.

Marta Coscia, MD, Silvia Peola, PhD, Giorgia Matta, MD, Francesca Pantaleoni, PhD, Myriam Foglietta, MD, Daniela Angelini, PhD, Sabina Chiaretti, MD, Chiara Riganti, MD, Anna Guarini, PhD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Robin Foà, MD, Luca Battistini, MD, Mario Boccadoro, MD, Jean Jacques Fournie, PhD, Massimo Massaia, MD
Journal: Blood
Blood (2007) 110 (11): 1131.
https://doi.org/10.1182/blood.V110.11.1131.1131
Published: 2007